Allianz Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
WHG
Allianz Asset Management's BSX.PRA Position: Q3 2022 in Review
Allianz Asset Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2022, closing a stake of 2,501,010 shares — an estimated $254M sold.
Allianz Asset Management first reported a position in BSX.PRA in Q2 2020 and held it in 5 quarters. The position peaked at $328M in Q1 2022. 54 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2022.
- Allianz Asset Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2022 after selling out during the quarter.
- Allianz Asset Management sold 2,501,010 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2022, an estimated $254M.
- Allianz Asset Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 5 quarters.
- Allianz Asset Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $328M in Q1 2022.
- 54 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2022.
Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.